pentoxifylline has been researched along with Central Retinal Edema, Cystoid in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cystoid macular edema (CME) is a rare complication of the paclitaxel." | 7.88 | Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report. ( Lee, YC; Shih, CH, 2018) |
| "To determine whether oral pentoxifylline, a xanthine-derived hemorheologic agent, decreases cystoid macular edema (CME) and improves visual acuity in eyes with a perfused central retinal vein occlusion (CRVO)." | 7.74 | Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion. ( Fekrat, S; Park, CH; Scott, AW, 2007) |
| "Cystoid macular edema (CME) is a rare complication of the paclitaxel." | 3.88 | Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report. ( Lee, YC; Shih, CH, 2018) |
| "To determine whether oral pentoxifylline, a xanthine-derived hemorheologic agent, decreases cystoid macular edema (CME) and improves visual acuity in eyes with a perfused central retinal vein occlusion (CRVO)." | 3.74 | Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion. ( Fekrat, S; Park, CH; Scott, AW, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shih, CH | 1 |
| Lee, YC | 1 |
| Park, CH | 1 |
| Scott, AW | 1 |
| Fekrat, S | 1 |
2 other studies available for pentoxifylline and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.
Topics: Antineoplastic Agents, Phytogenic; Electrooculography; Electroretinography; Female; Fluorescein Angi | 2018 |
Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion.
Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Fluorescein Angiography; Follow-Up Studies; H | 2007 |